Kronox Lab Sciences Intrinsic Value
Kronox Lab Sciences (KRONOX) median intrinsic value is ₹63.19 from 9 valuation models (range ₹32–₹121), vs current price ₹157.97 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read KRONOX dividend yield for the complete payout history and dividend yield track record.
KRONOX Valuation Methods Summary — DCF, Graham Number & P/E
Kronox Lab Sciences intrinsic value across 9 models vs current price ₹157.97 — upside/downside and value range per method. Analyse KRONOX shareholder distribution to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹90.12 | ₹72.10 - ₹108.14 | -43.0% | EPS: ₹7.51, Sector P/E: 12x |
| Book Value Method | asset | ₹31.59 | ₹28.43 - ₹34.75 | -80.0% | Book Value/Share: ₹31.35, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹47.39 | ₹42.65 - ₹52.13 | -70.0% | Revenue/Share: ₹27.30, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹63.19 | ₹56.87 - ₹69.51 | -60.0% | EBITDA: ₹34.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹113.81 | ₹91.05 - ₹136.57 | -28.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹120.16 | ₹108.14 - ₹132.18 | -23.9% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹61.59 | ₹55.43 - ₹67.75 | -61.0% | Revenue Growth: 5.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹121.08 | ₹108.97 - ₹133.19 | -23.4% | ROE: 24.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹62.70 | ₹56.43 - ₹68.97 | -60.3% | EPS: ₹7.51, BVPS: ₹31.35 |
KRONOX Intrinsic Value vs Market Price — All Valuation Models
Kronox Lab Sciences fair value range ₹32–₹121 vs current market price ₹157.97 across 9 valuation models. For current market price and key ratios, visit Kronox Lab Sciences screener.
KRONOX Intrinsic Value Analysis — Undervalued or Overvalued?
Kronox Lab Sciences median intrinsic value ₹63.19, current price ₹157.97 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of KRONOX?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Kronox Lab Sciences (KRONOX) is ₹63.19 (median value). With the current market price of ₹157.97, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹31.59 to ₹121.08, indicating ₹31.59 - ₹121.08.
Is KRONOX undervalued or overvalued?
Based on our multi-method analysis, Kronox Lab Sciences (KRONOX) appears to be trading above calculated value by approximately 60.0%.
KRONOX Financial Health — Key Ratios vs Industry Benchmarks
Kronox Lab Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 79.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 24.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 34.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.79x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KRONOX Cash Flow Quality — Operating & Free Cash Flow
Kronox Lab Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹31 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹17 Cr | ₹9 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹20 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |